86-10-69002900 globalsales@capitalbiotech.com
en
Email Us
Search Result Products

Search Result Products

All Related Products Other Content
  • The Disease Susceptibility Genetic Test-ADIPO The Disease Susceptibility Genetic Test-ADIPO This test is based on biochip technology and evaluates the influence of these loci on cardiovascular and cerebrovascular diseases, metabolic diseases, tumors and other diseases by detecting two loci of the adiponectin gene.
  • GJB2 Gene Coding Region and Splicing Site Detection GJB2 Gene Coding Region and Splicing Site Detection This test is based on NGS technology, and can provide information on whether the subject is carrying GJB2 gene-related deafness mutations.
  • The Disease Susceptibility Genetic Test-Full Package (150 Items) The Disease Susceptibility Genetic Test-Full Package (150 Items) This test is based on biochip technology and evaluates the risk of nearly 150 diseases in 13 categories from a genetic perspective.
  • The Disease Susceptibility Genetic Test-Obesity The Disease Susceptibility Genetic Test-Obesity This test is based on biochip technology and evaluates the genetic risk of obesity, the effect of different nutrients in the diet, different exercise methods on the weight loss effect, by detecting the genes related to the occurrence of obesity in the human body.
  • Human Mitochondrial Genome Detection Human Mitochondrial Genome Detection Mitochondrial diseases refer to a group of multi-system diseases caused by dysfunction of the mitochondrial respiratory chain, which leads to ATP synthesis disorder. They can occur in any part of the body or at any age, and the incidence is about 1/8500.
  • The Disease Susceptibility Genetic Test-High Myopia The Disease Susceptibility Genetic Test-High Myopia This test is based on biochip technology and evaluates the risk of high myopia by detecting innate susceptibility genes of the human body.
  • Clinical WES Clinical WES The Clinical WES test of CapitalBiotech is based on the BES4000 semiconductor sequencing platform, using target region capture and the NGS technology to detect nearly 4,000 genes that are clearly associated with genetic diseases, covering more than 4,200 diseases.
  • Individual WES Individual WES Covering 180,000+ exon regions of 20,000+ human genes, it comprehensively interprets all single-gene disorders with clear pathogenic genes in the OMIM database, and can search for new pathogenic genes with trio-WES method.
  • Metabolic Testing-Alcohol Metabolism Test Metabolic Testing-Alcohol Metabolism Test This test detects the genes related to alcohol metabolism in the human body and evaluates the alcohol metabolism ability of the subject.
  • WES+CNV-seq WES+CNV-seq The combination of individual WES and CNV-seq detects single-gene disorders and chromosomal diseases.
  • Metabolic Testing-Tobacco Damage Metabolic Testing-Tobacco Damage This test detects the metabolic process of chemical substances in tobacco and the genes related to the damage mechanism to the human body.
  • Metabolic Testing-Alcohol Damage Metabolic Testing-Alcohol Damage This test detects the metabolic process of chemical substances in alcohol and the genes related to the damage mechanism in the human body.
  • Metabolic Testing-Food Intolerance (50 Items) Metabolic Testing-Food Intolerance (50 Items) It covers 9 common food categories (including eggs and dairy, grains and nuts, meat, seafood, vegetables, fruits, yeast and beverages, seasonings, and traditional Chinese medicine) based on the microarray platform. It tests a total of 50 kinds of foods for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.
  • Metabolic Testing-Food Intolerance (101 Items) Metabolic Testing-Food Intolerance (101 Items) It covers 9 common food categories (including eggs and dairy, grains and nuts, meat, seafood, vegetables, fruits, yeast and beverages, seasonings, and traditional Chinese medicine) based on the microarray platform. It tests a total of 101 kinds of foods for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.
  • Intestinal Flora Testing Intestinal Flora Testing Intestinal flora testing uses a next-generation high-throughput sequencing platform and is based on 16S rDNA sequencing technology from the Human Microbiome Project.
Products
CapitalBiotech News & Blog
CapitalBiotech Continues to Promote the National Precision Medicine Center in Kyrgyzstan News
CapitalBiotech Continues to Promote the National Precision Medicine Center in Kyrgyzstan
25 Jun,2025
10
Jun 2025
CapitalBiotech's DNA Rapid Detection System Shines at Securex South Africa 2025 NEWS
29
Apr 2025
Advantages of NGS Genetic Testing NEWS
22
Apr 2025
A Brief Analysis of Microfluidic Technology NEWS
globalsales@capitalbiotech.com
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing
Products Instruments Consumbles
Sequencing Service Health Solutions
Quick Links
Contact Us
Copyright © CapitalBiotech Co., Ltd. All Rights Reserved.
Sitemap Privacy Policy